FDA clears QbTest for treatment follow-up

April 2, 2014 | Press Coverage | QbTest

1-minute summary: The US Food and Drug Administration (FDA) has cleared the neuropsychological test – QbTest – developed by the Swedish company Qbtech to aid in the evaluation of treatment interventions in patients with ADHD.

QbTest is a computer-based test providing clinicians with objective and unbiased decision-making support when diagnosing and treating ADHD in children, adolescents and adults. QbTest is the only test in the world cleared by the FDA for this usage.

Related Blogs

08 Mar

New publication: The National Institute for Clinical Excellence (NICE) appraises QbTest

1-minute summary: The National Institute for Clinical Excellence (NICE) publishes its Medtech innovation briefing [MIB318] for QbTest. The report highlights...
25 Jan

Dr. Howard Schub on improving patient care with objective ADHD testing

1-minute summary: In 2022, Dr. Howard Schub joined the Horwitz-Zusman Child & Family Center at Jewish Family & Career Services...
15 Dec

The role of ‘birthdate bias’ in the assessment of children with ADHD at school.

1-minute summary: In our previous blog on ADHD in children at school, we discussed the red flags adults and teachers...